Journal ArticleJCI insight · May 2024
Physician-scientists play a crucial role in advancing medical knowledge and patient care, yet the long periods of time required to complete training may impede expansion of this workforce. We examined the relationship between postgraduate training and time ...
Full textCite
Journal ArticleGenome Med · November 10, 2023
BACKGROUND: Chronic limb-threatening ischemia (CLTI), a severe manifestation of peripheral arterial disease (PAD), is associated with a 1-year limb amputation rate of approximately 15-20% and substantial mortality. A key feature of CLTI is the compromised ...
Full textLink to itemCite
Journal ArticleElife · October 2, 2023
The growing complexities of clinical medicine and biomedical research have clouded the career path for physician-scientists. In this perspective piece, we address one of the most opaque career stage transitions along the physician-scientist career path, th ...
Full textLink to itemCite
Journal ArticleFront Cardiovasc Med · 2023
Skeletal muscle injury in peripheral artery disease (PAD) has been attributed to vascular insufficiency, however evidence has demonstrated that muscle cell responses play a role in determining outcomes in limb ischemia. Here, we demonstrate that genetic ab ...
Full textLink to itemCite
Journal ArticleJ Ovarian Res · October 20, 2022
BACKGROUND: Epithelial ovarian cancer (OC) is the most lethal gynecological malignancy and patients present with significant metastatic burden, particularly to the adipose-rich microenvironment of the omentum. Recent evidence has highlighted the importance ...
Full textLink to itemCite
Journal ArticleDevelopment · September 15, 2022
Heart regeneration requires multiple cell types to enable cardiomyocyte (CM) proliferation. How these cells interact to create growth niches is unclear. Here, we profile proliferation kinetics of cardiac endothelial cells (CECs) and CMs in the neonatal mou ...
Full textLink to itemCite
Journal ArticleCell Rep · June 28, 2022
Ovarian cancer (OC) is the most lethal gynecological malignancy, with aggressive metastatic disease responsible for the majority of OC-related deaths. In particular, OC tumors preferentially metastasize to and proliferate rapidly in the omentum. Here, we s ...
Full textLink to itemCite
Journal ArticleFASEB J · May 2022
The Angiopoietin-Tie (Ang-Tie) pathway is a key signaling pathway regulating vascular stability and permeability, and it significantly intersects and crosstalk with the vascular endothelial growth factor (VEGF) signaling pathway, a major signaling pathway ...
Full textLink to itemCite
Journal ArticleJCI Insight · March 22, 2022
Postgraduate physician-scientist training programs (PSTPs) enhance the experiences of physician-scientist trainees following medical school graduation. PSTPs usually span residency and fellowship training, but this varies widely by institution. Applicant c ...
Full textLink to itemCite
Journal ArticleNPJ Syst Biol Appl · August 20, 2021
The Ang-Tie signaling pathway is an important vascular signaling pathway regulating vascular growth and stability. Dysregulation in the pathway is associated with vascular dysfunction and numerous diseases that involve abnormal vascular permeability and en ...
Full textLink to itemCite
Journal ArticleiScience · October 25, 2019
The angiopoietin-Tie signaling pathway is an important vascular signaling pathway involved in angiogenesis, vascular stability, and quiescence. Dysregulation in the pathway is linked to the impairments in vascular function associated with many diseases, in ...
Full textLink to itemCite
Journal ArticleJ Cell Physiol · April 2019
The pathophysiology of human immunodeficiency virus (HIV)-associated cardiomyopathy remains uncertain. We used HIV-1 transgenic (Tg26) mice to explore mechanisms by which HIV-related proteins impacted on myocyte function. Compared to adult ventricular myoc ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · October 1, 2018
IMPORTANCE: The prevalence of nonischemic dilated cardiomyopathy (DCM) is greater in individuals of African ancestry than in individuals of European ancestry. However, little is known about whether the difference in prevalence or outcomes is associated wit ...
Full textLink to itemCite
Journal ArticleJ Cell Physiol · September 2018
Bcl2-associated athanogene 3 (BAG3) is a 575 amino acid protein that is found predominantly in the heart, skeletal muscle, and many cancers. Deletions and truncations in BAG3 that result in haplo-insufficiency have been associated with the development of d ...
Full textLink to itemCite
Journal ArticleJ Cell Physiol · February 2018
Cardiovascular disease remains a leading cause of morbidity and mortality in HIV-positive patients, even in those whose viral loads are well controlled with antiretroviral therapy. However, the underlying molecular events responsible for the development of ...
Full textLink to itemCite
Journal ArticleJACC Basic Transl Sci · February 2018
The B-cell lymphoma 2-associated anthanogene (BAG3) protein is expressed most prominently in the heart, the skeletal muscle, and in many forms of cancer. In the heart, it serves as a co-chaperone with heat shock proteins in facilitating autophagy; binds to ...
Full textLink to itemCite
Journal ArticleCirculation · July 18, 2017
BACKGROUND: Critical limb ischemia is a manifestation of peripheral artery disease that carries significant mortality and morbidity risk in humans, although its genetic determinants remain largely unknown. We previously discovered 2 overlapping quantitativ ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · March 1, 2017
Pathogenic mycobacteria trigger formation of organized granulomas. As granulomas mature, they induce angiogenesis and vascular permeability. Here, in a striking parallel to tumor pro-angiogenic signaling, we identify angiopoietin-2 (ANG-2) induction as an ...
Full textLink to itemCite
Journal ArticleCardiovasc Res · January 2017
AIMS: Atherosclerosis is a chronic inflammatory disease occurring within the artery wall. A crucial step in atherogenesis is the infiltration and retention of monocytes into the subendothelial space of large arteries induced by chemokines and growth factor ...
Full textLink to itemCite
Journal ArticleJ Vasc Surg · October 2016
OBJECTIVE: The primary preclinical model of peripheral artery disease, which involves acute limb ischemia (ALI), can result in appreciable muscle injury that is attributed to the acuity of the ischemic injury. A less acute model of murine limb ischemia usi ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · September 1, 2016
Angiopoietin-1/Tie2 (ANG1/Tie2) signaling is well documented as regulating angiogenesis and vessel maturation. This pathway is complicated by involvement of the orphan receptor Tie1, which has been implicated as both a positive and negative regulator of AN ...
Full textLink to itemCite
Journal ArticleJ Vis Exp · June 21, 2016
Peripheral artery disease (PAD) is a leading cause of cardiovascular morbidity and mortality in developed countries, and animal models that reliably reproduce the human disease are necessary to develop new therapies for this disease. The mouse hindlimb isc ...
Full textLink to itemCite
Journal ArticleAm J Physiol Regul Integr Comp Physiol · April 1, 2015
Activation of muscle progenitor cell myogenesis and endothelial cell angiogenesis is critical for the recovery of skeletal muscle from injury. Angiopoietin-1 (Ang-1), a ligand of Tie-2 receptors, enhances angiogenesis and skeletal muscle satellite cell sur ...
Full textLink to itemCite
Journal ArticleFront Physiol · 2015
Recent strategies to treat peripheral arterial disease (PAD) have focused on stem cell based therapies, which are believed to result in local secretion of vascular growth factors. Little is known, however, about the role of ischemic endogenous cells in thi ...
Full textLink to itemCite
Journal ArticlePLoS One · 2015
The endothelial receptor tyrosine kinase (RTK) Tie1 was discovered over 20 years ago, yet its precise function and mode of action remain enigmatic. To shed light on Tie1's role in endothelial cell biology, we investigated a potential threonine phosphorylat ...
Full textLink to itemCite
Chapter · January 1, 2015
Despite advances in the medical management of atherosclerosis, surgical revascularization using autologous veins remains a mainstay of therapy for both coronary and peripheral artery disease. However, long-term outcomes following bypass surgery are limited ...
Full textCite
Journal ArticleJ Clin Invest · October 2014
Retinal and choroidal neovascularization (NV) and vascular leakage contribute to visual impairment in several common ocular diseases. The angiopoietin/TIE2 (ANG/TIE2) pathway maintains vascular integrity, and negative regulators of this pathway are potenti ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · January 2014
Epidemiological studies have identified racial differences in susceptibility to numerous diseases, including several ocular and skin diseases characterized by increased vascular growth. In most cases, the specific mechanisms and genetic variants responsibl ...
Full textLink to itemCite
Journal Article · December 1, 2013
Peripheral artery disease (PAD) is characterized by impaired blood flow to the lower extremities causing claudication, exercise intolerance and a decreased quality of life. Despite the fact that stenosis of conduit vessels are largely responsible for PAD d ...
Cite
Journal ArticleTransl Res · April 2013
Ischemic cardiovascular disease remains the leading cause of death worldwide. Despite advances in the medical management of atherosclerosis over the past several decades, many patients require arterial revascularization to reduce mortality and alleviate is ...
Full textLink to itemCite
Journal ArticleSci Signal · July 24, 2012
Radiation therapy, which is used for the treatment of some cancers, can cause delayed heart damage. In the heart, p53 influences myocardial injury that occurs after multiple types of stress. Here, we demonstrated that p53 functioned in endothelial cells to ...
Full textLink to itemCite
Journal ArticleAm J Pathol · May 2012
Genetics plays an important role in determining peripheral arterial disease (PAD) pathology, which causes a spectrum of clinical disorders that range from clinically silent reductions in blood flow to limb-threatening ischemia. The cell-type specificity of ...
Full textLink to itemCite
Journal ArticleJ Control Release · October 30, 2011
Antivascular targeting is a promising strategy for tumor therapy. This strategy has the potential to overcome many of the transport barriers associated with targeting tumor cells in solid tumors, because the tumor vasculature is directly accessible to targ ...
Full textLink to itemCite
Journal ArticleFree Radic Biol Med · March 1, 2011
Cadmium (Cd), a highly toxic environmental pollutant, induces neurodegenerative diseases. Recently we have demonstrated that Cd induces neuronal apoptosis in part through activation of the mammalian target of rapamycin (mTOR) pathway. However, the underlyi ...
Full textLink to itemCite
Journal ArticleAm J Physiol Heart Circ Physiol · June 2010
Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis, the growth of new capillaries from existing microvasculature. In peripheral arterial disease (PAD), lower extremity muscle ischemia develops downstream of atherosclerotic obstruc ...
Full textLink to itemCite
Journal ArticleCardiovasc Res · May 1, 2010
AIMS: Phosphatase and tensin homolog (PTEN) is implicated as a negative regulator of vascular smooth muscle cell (SMC) proliferation and injury-induced vascular remodelling. We tested if selective depletion of PTEN only in SMC is sufficient to promote SMC ...
Full textLink to itemCite
Journal ArticleJ Cell Mol Med · March 2010
Angiogenesis is the growth of new capillaries from pre-existent microvasculature. A wide range of pathological conditions, from atherosclerosis to cancer, can be attributed to either excessive or deficient angiogenesis. Central to the physiological regulat ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · November 20, 2009
Prostaglandin E(2) (PGE(2)) is an arachidonic acid metabolite that counters transforming growth factor-beta-induced fibroblast activation via E prostanoid 2 (EP2) receptor binding. Phosphatase and tensin homologue on chromosome 10 (PTEN) is a lipid phospha ...
Full textLink to itemCite
Journal ArticleCirc Res · June 19, 2009
Featured Publication
Atherosclerosis is promoted by a combination of hypercholesterolemia and vascular inflammation. The function of Angiopoietin (Ang)-2, a key regulator of angiogenesis, in the maintenance of large vessels is unknown. A single systemic administration of Ang-2 ...
Full textLink to itemCite
Journal ArticlePhysiol Genomics · June 10, 2009
Vascular endothelial growth factor (VEGF) signal transduction through the cell surface receptors VEGFR1 and VEGFR2 regulates angiogenesis-the growth of new capillaries from preexistent microvasculature. Soluble VEGF receptor-1 (sVEGFR1), a nonsignaling tru ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · April 14, 2009
Despite substantial evidence that nitric oxide (NO) and/or endogenous S-nitrosothiols (SNOs) exert protective effects in a variety of cardiovascular diseases, the molecular details are largely unknown. Here we show that following left coronary artery ligat ...
Full textLink to itemCite
Journal ArticleHepatology · December 2008
Hepatic apolipoprotein B (apoB) lipoprotein production is metabolically regulated via the phosphoinositide 3-kinase cascade; however, the role of the key negative regulator of this pathway, the tumor suppressor phosphatase with tensin homology (PTEN), is u ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · October 31, 2008
Vascular endothelial cells (ECs) have a finite lifespan when cultured in vitro and eventually enter an irreversible growth arrest state called "cellular senescence." It has been shown that sphingolipids may be involved in senescence; however, the molecular ...
Full textLink to itemCite
Journal ArticleJ Sex Med · September 2008
Featured Publication
INTRODUCTION: Hypercholesterolemia causes a decrease in normal corporal tissue vasoreactivity in a preclinical model of erectile dysfunction. Previous studies have shown that intracorporal injection (ICI) of basic fibroblast growth factor (bFGF) reverses s ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · July 29, 2008
Featured Publication
OBJECTIVES: Our purpose was to determine whether factors that regulate angiogenesis are altered in peripheral arterial disease (PAD) and whether these factors are associated with the severity of PAD. BACKGROUND: Alterations in angiogenic growth factors occ ...
Full textLink to itemCite
Journal ArticleJ Sex Med · May 2008
INTRODUCTION: Angiogenesis, the growth and proliferation of blood vessels from existing vascular structures, is mediated by many cytokine growth factors and receptors, among the most important are the vascular endothelial growth factor (VEGF) family. AIM: ...
Full textLink to itemCite
Journal ArticleJ Surg Res · May 1, 2008
BACKGROUND: Cellular events mediated by the Tie2 receptor are important to tumor neovascularization. Despite the complex interplay of the best-characterized Tie2 ligands, angiopoietins 1 and 2, Ang2 is purportedly "proangiogenic" in the presence of vascula ...
Full textLink to itemCite
Journal ArticleMol Ther · January 2008
Due to the prevalence of tumor chemoresistance, the clinical response of advanced non-small cell lung cancer (NSCLC) to chemotherapy is poor. We suppressed tumor resistance to doxorubicin (Dox) in A549 cells, a human NSCLC cell line, both in vitro and in v ...
Full textLink to itemCite
Journal ArticleAngiogenesis · 2008
Featured Publication
Tie2 is a receptor tyrosine kinase that is expressed predominantly in the endothelium and plays key roles in both physiological and pathological angiogenesis. The ligands for Tie2, the angiopoietins (Ang), perform opposing functions in vascular maintenance ...
Full textLink to itemCite
Journal ArticleArterioscler Thromb Vasc Biol · December 2007
Featured Publication
OBJECTIVE: Tie2 and its ligands, the angiopoietins (Ang), are required for embryonic and postnatal angiogenesis. Previous studies have demonstrated that Tie2 is proteolytically cleaved, resulting in the production of a 75-kDa soluble receptor fragment (sTi ...
Full textLink to itemCite
Journal ArticleCirc Res · October 26, 2007
Featured Publication
Deficient angiogenesis after ischemia may contribute to worse outcomes of peripheral arterial disease in patients with diabetes mellitus (DM). Vascular endothelial growth factor (VEGF) and its receptors promote angiogenesis. We hypothesized that in periphe ...
Full textLink to itemCite
Journal ArticleCancer Res · April 15, 2007
Angiopoietin-2 (Ang-2) is a conditional antagonist and agonist for the endothelium-specific Tie-2 receptor. Although endogenous Ang-2 cooperates with vascular endothelial growth factor (VEGF) to protect tumor endothelial cells, the effect on tumor vasculat ...
Full textLink to itemCite
Journal ArticleCurr Opin Mol Ther · April 2007
Featured Publication
Angiogenesis is defined as the growth and proliferation of blood vessels from existing vascular structures. Therapeutic angiogenesis seeks to harness the mechanisms of vascular growth to treat disorders of inadequate tissue perfusion. Early clinical trials ...
Link to itemCite
Journal ArticleDiabetes · March 2007
Featured Publication
Peripheral arterial disease is a major complication of diabetes. The ability to promote therapeutic angiogenesis may be limited in diabetes. Type 2 diabetes was induced by high-fat feeding C57BL/6 mice (n = 60). Normal chow-fed mice (n = 20) had no diabete ...
Full textLink to itemCite
Journal ArticleCirc Res · October 13, 2006
Endothelial cell dysfunction and apoptosis are critical in the pathogenesis of atherosclerotic cardiovascular disease (CVD). Both endothelial cell apoptosis and atherosclerosis are reduced by high-density lipoprotein (HDL). Low HDL levels increase the risk ...
Full textLink to itemCite
Journal ArticleJ Vasc Surg · July 2006
Featured Publication
OBJECTIVE: Angiogenesis is the growth and proliferation of blood vessels from existing vascular structures, and therapeutic angiogenesis seeks to promote blood vessel growth to improve tissue perfusion. Vascular endothelial growth factor (VEGF) is a protot ...
Full textLink to itemCite
Journal ArticleAm J Physiol Heart Circ Physiol · July 2006
Skin ischemic necrosis due to vasospasm and/or insufficient vascularity is the most common complication in the distal portion of the skin flap in reconstructive surgery. This project was designed to test our hypothesis that preoperative subdermal injection ...
Full textLink to itemCite
Journal ArticleJ Surg Res · March 2006
Angiogenesis is essential for solid tumor growth. Although successful antiangiogenic therapies have been demonstrated in animal models, a systematic comparison of the efficacy of different antiangiogenic factors has not been described in the hepatic enviro ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · January 1, 2006
Featured Publication
RATIONALE: Myofibroblasts are primary effector cells in idiopathic pulmonary fibrosis (IPF). Defining mechanisms of myofibroblast differentiation may be critical to the development of novel therapeutic agents. OBJECTIVE: To show that myofibroblast differen ...
Full textLink to itemCite
Journal ArticleNucleic Acids Res · 2006
Aptamers offer advantages over other oligonucleotide-based approaches that artificially interfere with target gene function due to their ability to bind protein products of these genes with high affinity and specificity. However, RNA aptamers are limited i ...
Full textLink to itemCite
Journal ArticleCancer Res · December 15, 2005
In normal epithelial tissues, the multifunctional cytokine transforming growth factor-beta (TGF-beta) acts as a tumor suppressor through growth inhibition and induction of differentiation whereas in advanced cancers, TGF-beta promotes tumor progression thr ...
Full textLink to itemCite
Journal ArticleJ Sex Med · September 2005
PURPOSE: Hypercholesterolemia is a major risk factor for erectile dysfunction (ED), but the mechanisms are not completely understood. Vascular endothelial growth factor (VEGF) is reduced in rabbit corporal tissue with cholesterol feeding. VEGF signaling le ...
Full textLink to itemCite
Journal ArticleNat Med · September 2005
Featured Publication
Nitric oxide (NO) production by endothelial cell nitric oxide synthase (eNOS) in sinusoidal endothelial cells is reduced in the injured liver and leads to intrahepatic portal hypertension. We sought to understand the mechanism underlying defective eNOS fun ...
Full textLink to itemCite
Journal ArticleBiochem Biophys Res Commun · June 24, 2005
This study was designed to determine if soluble Tie2 (sTie2) expression inhibits and regresses corneal neovascularization, and if VEGF contributes to its effect. The corneas of BALB/c mice were scraped and the mice were injected with either an adenovirus e ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · June 2005
Featured Publication
OBJECTIVES: Fifty percent of human aortocoronary saphenous vein grafts are occluded after 10 years. Intimal hyperplasia is an initial step in graft occlusion and consists of vascular smooth muscle cell proliferation. Phosphatidylinositol 3-kinase and its d ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · March 22, 2005
PTEN, a tumor suppressor phosphatase, is important in the regulation of cell migration and invasion. Physiological regulation of PTEN (phosphatase and tensin homolog deleted on chromosome 10) by cell surface receptors has not been described. Here, we show ...
Full textLink to itemCite
Journal ArticleArterioscler Thromb Vasc Biol · February 2005
Featured Publication
OBJECTIVE: Phosphoinositide (PI) 3-kinase promotes vascular smooth muscle cell (VSMC) responses necessary for neointimal hyperplasia. We recently demonstrated that the inositol 3-phosphatase PTEN is expressed in VSMCs and that its overexpression inhibits t ...
Full textLink to itemCite
Chapter · January 1, 2005
Angiogenesis is defined as the growth and proliferation of blood vessels from existing vascular structures (1, 2). Since blood vessels sub-serve the critical biological function of delivering oxygen and removing toxins from target organs, this part of the ...
Full textCite
Journal ArticleAm J Physiol Regul Integr Comp Physiol · November 2004
Distal skin ischemic necrosis is a common complication in skin flap surgery. The pathogenesis of skin flap ischemic necrosis is unclear, and there is no clinical treatment available. Here, we used the 4 x 10 cm rat dorsal skin flap model to test our hypoth ...
Full textLink to itemCite
Journal ArticleCirculation · October 19, 2004
Featured Publication
BACKGROUND: Therapeutic angiogenesis seeks to promote blood vessel growth to improve tissue perfusion. Vascular endothelial growth factor (VEGF) exists in multiple isoforms. We investigated an engineered zinc finger-containing transcription factor plasmid ...
Full textLink to itemCite
Journal ArticleCirc Res · August 6, 2004
Endothelial cell (EC) proliferation and migration are important for reendothelialization and angiogenesis. We have demonstrated that reactive oxygen species (ROS) derived from the small GTPase Rac1-dependent NAD(P)H oxidase are involved in vascular endothe ...
Full textLink to itemCite
Journal ArticleAm J Pathol · February 2004
Tie2 is an endothelial cell-specific receptor tyrosine kinase, whose activation is positively and negatively modulated by angiopoietin-1 and angiopoietin-2, respectively. Angiopoietin-mediated modulation of Tie2 activation contributes to normal vessel deve ...
Full textLink to itemCite
Journal ArticleFASEB J · February 2004
Neoplastic cells overexpress several angiogenic cytokines, which stimulate neovascularization. Whether the responses of the host endothelial cells to these signaling molecules affect tumor cells during early tumorigenesis has not been investigated. We inve ...
Full textLink to itemCite
Journal ArticleRecent Prog Horm Res · 2004
Featured Publication
Abundant data now demonstrate that the growth of new blood vessels, termed angiogenesis, plays both pathological and beneficial roles in human disease. Based on these data, a tremendous effort has been undertaken to understand the molecular mechanisms that ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · December 12, 2003
Endothelin-1 has dual vasoactive effects, mediating vasoconstriction via ETA receptor activation of vascular smooth muscle cells and vasorelaxation via ETB receptor activation of endothelial cells. Although it is commonly accepted that endothelin-1 binding ...
Full textLink to itemCite
Journal ArticleDiabetes · December 2003
Vascular insufficiency and retinal ischemia precede many proliferative retinopathies and stimulate secretion of various vasoactive growth factors, including vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF). It is unclear, however ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · April 29, 2003
Featured Publication
Angiopoietin-2 (Ang2) appears to be a naturally occurring antagonist of the endothelial receptor tyrosine kinase Tie2, an important regulator of vascular stability. Destabilization of the endothelium by Ang2 is believed to potentiate the actions of proangi ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · August 30, 2002
Featured Publication
Tie2 is an endothelial receptor tyrosine kinase that is required for both embryonic vascular development and tumor angiogenesis. There is considerable interest in understanding the mechanisms of Tie2 activation for therapeutic purposes. The recent solution ...
Full textLink to itemCite
Journal ArticleArterioscler Thromb Vasc Biol · May 1, 2002
Phosphatidylinositol (PI) 3-kinase signaling regulates numerous cellular processes, including proliferation, migration, and survival, which are required for neointimal hyperplasia and restenosis. The effectors of PI 3-kinase are activated by the phospholip ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · March 29, 2002
Featured Publication
Phosphatidylinositol 3-kinase is activated by vascular endothelial growth factor (VEGF), and many of the angiogenic cellular responses of VEGF are regulated by the lipid products of phosphatidylinositol 3-kinase. The tumor suppressor PTEN has been shown to ...
Full textLink to itemCite
Journal ArticleMol Cell Biol · March 2002
Featured Publication
Tie1 is an orphan receptor tyrosine kinase that is expressed almost exclusively in endothelial cells and that is required for normal embryonic vascular development. Genetic studies suggest that Tie1 promotes endothelial cell survival, but other studies hav ...
Full textLink to itemCite
Journal ArticleAm J Pathol · September 2001
The known responses of vascular endothelial growth factor (VEGF) are mediated through VEGF receptor-2 (VEGFR-2/KDR) in endothelial cells. However, it is unknown whether VEGFR-1 (Flt-1) is an inert decoy or a signaling receptor for VEGF during physiological ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · December 31, 1999
Angiogenesis is a tightly controlled process in which signaling by the receptors for vascular endothelial growth factor (VEGF) plays a key role. In order to define signaling pathways downstream of VEGF receptors (VEGFR), the kinase domain of VEGFR2 (Flk-1) ...
Full textLink to itemCite
Journal ArticleCurr Atheroscler Rep · September 1999
Angiogenesis, the growth and proliferation of blood vessels from existing vascular structures, is tightly regulated in adult tissues, and abnormalities in angiogenesis are associated with a number of pathologic states. Strategies designed to promote angiog ...
Full textLink to itemCite
Journal ArticleHum Mol Genet · July 1999
Venous malformations are low-flow vascular lesions consisting of disorganized thin-walled vascular channels. These can occur sporadically but also as an autosomal dominant condition termed venous malformations, cutaneous and mucosal (VMCM; OMIM 600195). In ...
Full textLink to itemCite
Journal ArticleMol Cell Biol · July 1998
Featured Publication
Tie2 is an endothelium-specific receptor tyrosine kinase that is required for both normal embryonic vascular development and tumor angiogenesis and is thought to play a role in vascular maintenance. However, the signaling pathways responsible for the funct ...
Full textLink to itemCite
Journal ArticleBr J Cancer · 1998
Endothelial receptor tyrosine kinases may play important roles in pathological vascular growth, particularly in tumours. In this study, immunohistochemistry was used to evaluate the expression of a novel endothelial receptor tyrosine kinase, Tie2/Tek, in t ...
Full textLink to itemCite
Journal ArticleAm J Physiol · October 1992
We used a cytochemical technique for the detection of superoxide in cerebral inflammation and ischemia-reperfusion in anesthetized cats. The technique is based on the oxidation of Mn2+ to Mn3+ by superoxide; Mn3+, in turn, oxidizes diaminobenzidine. The ox ...
Full textLink to itemCite